A Food and Drug Administration (FDA) draft guidance would require manufacturers of pulse oximeters to gather far more clinical data to show the devices accurately work across a range of skin tones. The long-awaited guidance released Monday comes in response to mounting evidence that the devices, which are used to quickly estimate a person’s blood...
Fact focus: False and misleading claims made by RFK Jr. in Senate hearing
- today, 7:57 PM
- nbcwashington.com
- 0

No comments